| Literature DB >> 35800557 |
Maheswar Samanta1,2, Manasi Mishra3, Ashok Kumar Mallick2, Kali Prasanna Swain2, Subhankar Mishra2.
Abstract
Background: Monomelic amyotrophy (MMA) is a benign, rare, sporadic disorder of adolescent and young adults with male predominance, where neurogenic amyotrophy is restricted to an upper or lower limb. It is a variant of lower motor neuron disorder with insidious onset and slow progression for 2-4 years. Paucity of cohort studies as well as relative unawareness among physicians in eastern India stimulated us to do this work. Material andEntities:
Keywords: Electromyography; Monomelic amyotrophy; Motor neuron disease
Year: 2022 PMID: 35800557 PMCID: PMC9254804 DOI: 10.4103/jfmpc.jfmpc_1340_21
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
(several previous studies)
| Study | Numbers of cases | Salient features |
|---|---|---|
| Gouri devi | 44 | mean age at onset 19.8 years with a range of 13-32 years |
| Atchayaram Nalini | 279 | Mean age of onset was 19.5±4.18 |
| Freitas MR | 21 | age of onset ranged from 4 to 41 |
| Khandelwal D | 35 | All the patients, bilateral chronic reinnervative changes and 50% had chronic reinnervative changes in three limbs |
Graph 1Showing distribution of occupation
Graph 2Showing pattern of muscle atrophy and weakness of upper limb
Photo 1Showing wasting of muscles of left hand & left forearm with sparing brachioradialis
Photo 2Showing wasting of small muscles of left hand
Photo 3Showing wasting of left shoulder girdle muscles
Graph 3Showing pattern of muscle atrophy and weakness of lower limb
Photo 4Showing atrophy of left thigh muscles
Figure 1EMG Report showing incomplete Interference Pattern
Figure 2MRI Cervical spine showing contrast enhancement of post. epidural space
(Epidemiological and clinical pictures of MMA in this study)
| FEATURES OF MMA IN PRESENT STUDY | |||
|---|---|---|---|
| Mean age of presentation (years) | 21.77 (14-39) | ||
| Mean age of onset (years) | 19.6 (12-31) | ||
| M: F | 34:1 | ||
| Familial involvement | 4 (2.8) | ||
| Mean duration of progression of disease (yrs) | 2.4 | ||
| Course of disease | Progressive | Progressive – stationary phase | 100 (71.4) |
| Late progressive (beyond 3 yr) | 16 (11.4%) | ||
| stationary | 24 (17%) | ||
| Upper Limb (U/L involvement) | 90 (62.2%) | ||
| Upper Limb (B/L involvement) | 26 (18.5) | ||
| Lower Limb (U/L involvement) | 12 (8.5) | ||
| Wasting Distal only (UL &LL) | 118 (84.2) | ||
| Wasting Proximal only (UL &LL) | 20 (14.2) | ||
| Wasting Global only (Whole Limb) | 2 (1.4) | ||
| Bilateral Upper Limb distal wasting | 26 (18.5) | ||
| Areflexia in affected limb | 96 (69) | ||
| Areflexia in contralateral limb | 21 (15) | ||
| Hyper-reflexia affected limb | 8 (5.7) | ||
| Fasciculation of affected muscle | 16 (11) | ||
| Tremor in only affected Limb | 86 (61) | ||
| Tremor in both limb (affected & contralateral) | 19 (13.5) | ||
| Autonomic features | Affected limb | 30 (21.3) | |
| B/L Homologous limbs | 4 (2.8) | ||
| Motor symptoms (On cold exposure) : Cold paresis | 6 (4) | ||
B/L : BILATERAL, U/L: UNILATERAL, UL: UPPER LIMB, LL: LOWER LIMB M: Male, F: Female